The symptoms of NiV infection include fever, respiratory distress, and encephalitis. There is no specific treatment or vaccine for NiV infection, and the only way to prevent it is by avoiding exposure to the virus.

Nipah virus is a zoonotic virus that can cause severe and often fatal disease in humans and animals.

FKCCI Announces India CSR & Sustainability Conference & Awards 2025

Introduction

Nipah virus (NiV) is a zoonotic virus, which means it can be transmitted from animals to humans and vice versa. It is one of the most deadly and emerging infectious diseases, with a high mortality rate and no specific treatment or vaccine available. NiV can cause a range of clinical manifestations, from asymptomatic infection to acute respiratory illness and fatal encephalitis. NiV can also cause severe disease in animals, especially pigs, resulting in significant economic losses for farmers. In this article, we will explore how NiV affects humans and animals, what are the symptoms, diagnosis, treatment, and prevention of NiV infection, and what are the challenges and opportunities for NiV research and control.

How does NiV infect humans and animals?

NiV belongs to the family of paramyxoviruses, which are enveloped RNA viruses that can infect various hosts. The natural reservoir of NiV is fruit bats of the genus Pteropus, also known as flying foxes. These bats can carry the virus without showing any signs of illness and can shed it in their saliva, urine, feces, and blood.

NiV can infect humans through different modes of transmission:

Consumption of fruits or fruit products (such as raw date palm juice) contaminated with bat secretions or excretions.
Direct contact with infected bats or their tissues or fluids.
Direct contact with infected pigs or their tissues or fluids.
Direct contact with infected humans or their tissues or fluids.

NiV can also infect animals through similar modes of transmission:

Consumption of fruits or fruit products contaminated with bat secretions or excretions.
Direct contact with infected bats or their tissues or fluids.
Direct contact with infected pigs or their tissues or fluids.
Direct contact with infected humans or their tissues or fluids.

What are the symptoms of NiV infection in humans and animals?

The incubation period of NiV infection in humans ranges from 4 to 14 days, but can be as long as 45 days. The symptoms of NiV infection in humans vary depending on the severity and type of infection:

Asymptomatic infection: Some people may not show any signs or symptoms of NiV infection, but may still be able to transmit the virus to others.
Acute respiratory infection: Some people may develop mild to severe respiratory symptoms, such as fever, cough, sore throat, difficulty breathing, chest pain, and pneumonia.
Encephalitis: Some people may develop severe neurological symptoms, such as fever, headache, drowsiness, confusion, seizures, coma, and death. Encephalitis is the most common and fatal complication of NiV infection in humans.

The incubation period of NiV infection in animals is not well known, but it may vary depending on the species and strain of the virus. The symptoms of NiV infection in animals also vary depending on the severity and type of infection:

Asymptomatic infection: Some animals may not show any signs or symptoms of NiV infection, but may still be able to transmit the virus to others.
Respiratory disease: Some animals may develop mild to severe respiratory symptoms, such as fever, coughing, sneezing, nasal discharge, difficulty breathing, and pneumonia.
Neurological disease: Some animals may develop severe neurological symptoms, such as fever, tremors, muscle spasms, paralysis, convulsions, coma, and death. Neurological disease is more common and fatal in pigs than in other animals.

How is NiV diagnosed and treated in humans and animals?

The diagnosis of NiV infection in humans and animals is based on clinical signs and symptoms, epidemiological history (such as exposure to bats or pigs), and laboratory tests. The laboratory tests include:

Detection of viral RNA by polymerase chain reaction (PCR) from blood, cerebrospinal fluid (CSF), urine, throat swab, nasal swab, or tissue samples.
Detection of viral antigen by enzyme-linked immunosorbent assay (ELISA) from blood, CSF, urine, throat swab, nasal swab, or tissue samples.
Detection of viral antibodies by ELISA or neutralization test from blood or CSF samples.

The treatment of NiV infection in humans and animals is mainly supportive care. There is no specific antiviral drug or vaccine available for NiV infection. The supportive care includes:

Isolation and barrier nursing of infected patients or animals to prevent further transmission.
Hydration and nutrition support for dehydration and malnutrition.
Oxygen therapy for respiratory distress.
Antipyretics for fever.
Analgesics for pain relief.
Anticonvulsants for seizures.
Antibiotics for secondary bacterial infections.

How can NiV infection be prevented and controlled in humans and animals?

The prevention and control of NiV infection in humans and animals requires a multidisciplinary and multisectoral approach, involving health, veterinary, wildlife, agriculture, and environmental sectors. The prevention and control measures include:

Surveillance and monitoring of NiV outbreaks and cases in humans and animals.
Education and awareness of NiV transmission, symptoms, diagnosis, treatment, and prevention among the public, health workers, veterinarians, farmers, and other stakeholders.
Avoidance of consumption of fruits or fruit products contaminated with bat secretions or excretions.
Avoidance of direct contact with infected bats or their tissues or fluids.
Avoidance of direct contact with infected pigs or their tissues or fluids.
Avoidance of direct contact with infected humans or their tissues or fluids.
Use of personal protective equipment (PPE) such as gloves, masks, gowns, and goggles when handling or caring for infected patients or animals.
Disinfection and disposal of contaminated materials and wastes from infected patients or animals.
Culling of infected pigs or other animals to reduce the viral load in the environment.
Vaccination of susceptible animals with experimental vaccines to prevent NiV infection.

What are the challenges and opportunities for NiV research and control?

NiV is a complex and unpredictable disease that poses a serious threat to human and animal health. There are many challenges and opportunities for NiV research and control, such as:

The lack of rapid, accurate, and affordable diagnostic tests for NiV infection in humans and animals.
The lack of effective and safe antiviral drugs and vaccines for NiV infection in humans and animals.
The lack of understanding of the ecology, epidemiology, pathogenesis, immunity, and evolution of NiV in different hosts and environments.
The need for collaboration and coordination among different disciplines, sectors, countries, and regions to share information, resources, expertise, and best practices for NiV prevention and control.
The need for ethical, social, cultural, and economic considerations in the design and implementation of NiV research and control interventions.

NiV is a priority disease for the World Health Organization (WHO) Research and Development Blueprint, which aims to accelerate the development of medical products for diseases that have the potential to cause public health emergencies. The WHO has also established a Global Nipah Research Consortium to foster collaboration among researchers working on NiV. These initiatives provide opportunities for advancing the knowledge and tools for NiV research and control.

Conclusion

Nipah virus is a zoonotic virus that can cause severe and often fatal disease in humans and animals. It is transmitted from bats to humans and animals through contaminated fruits or direct contact. The symptoms of NiV infection include fever, respiratory distress, and encephalitis. There is no specific treatment or vaccine for NiV infection, and the only way to prevent it is by avoiding exposure to the virus. NiV is a complex and unpredictable disease that requires a multidisciplinary and multisectoral approach to prevent and control. There are many challenges and opportunities for NiV research and control, such as developing rapid diagnostic tests, effective antiviral drugs and vaccines, understanding the ecology and epidemiology of NiV, and fostering collaboration and coordination among different stakeholders.

Also Read: Nipah virus in India: A deadly outbreak and its challenges